Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Halo Technology Holdings, Inc.Listing unverified | AwardD (derivative) | $113.4K | SEC | ||
Halo Technology Holdings, Inc.Listing unverified | AwardD (derivative) | $42K | SEC | ||
Halo Technology Holdings, Inc.Listing unverified | AwardD (derivative) | $122K | SEC | ||
Halo Technology Holdings, Inc.Listing unverified | Buy | $11.9K | conv 48ClusterFirst in 12mo | SEC | |
Halo Technology Holdings, Inc.Listing unverified | Buy | $18K | conv 53ClusterFirst in 12mo | SEC | |
Halo Technology Holdings, Inc.Listing unverified | Buy | $22.6K | conv 71ClusterFirst in 12mo | SEC | |
Halo Technology Holdings, Inc.Listing unverified | Buy | $1.2K | conv 40ClusterFirst in 12mo | SEC | |
Halo Technology Holdings, Inc.Listing unverified | AwardD (derivative) | $161.3K | SEC | ||
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $27.7K | conv 48First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $3.4K | conv 48First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $3.5K | conv 36First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $27.7K | conv 48First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $3.4K | conv 36First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | Buy | $3.5K | conv 48First in 12mo | SEC | |
HALOZYME THERAPEUTICS, INC.Listing on record | AwardD (derivative) | $81.6K | SEC | ||
NEUROCRINE BIOSCIENCES INCListing on record | AwardD (derivative) | $605.9K | SEC | ||
NEUROCRINE BIOSCIENCES INCListing on record | AwardD (derivative) | $1.2M | SEC |